AAT: does it have a place in acute leukemia?

dc.authoridSERIN, Istemi/0000-0003-1855-774X
dc.authoridDogu, Mehmet Hilmi/0000-0001-7237-2637
dc.authorwosidSERIN, Istemi/GRX-7028-2022
dc.contributor.authorDogu, Mehmet H.
dc.contributor.authorOzcelik, Berfin
dc.contributor.authorAkbulut, Yusuf E.
dc.contributor.authorKantarci, Mert
dc.contributor.authorBektas, Ezgi
dc.contributor.authorSerin, Istemi
dc.date.accessioned2024-05-19T14:38:45Z
dc.date.available2024-05-19T14:38:45Z
dc.date.issued2024
dc.departmentİstinye Üniversitesien_US
dc.description.abstractAim: In this study, the authors aimed to investigate the change of AAT, its effect on the response to induction and its effects on the treatment process in acute myeloid leukemia and acute lymphoblastic leukemia patients. Materials & methods: This study included 94 patients who were hospitalized and followed up in Istanbul Training and Research Hospital, Hematology Clinic, between October 2019 and December 2021. Results: Patients with a complete response had higher serum AAT levels than those with a non-complete response (p < 0.05). The mean serum AAT level was found to be significantly higher in patients without Gram-positive growth than in patients with Gram-positive growth. Conclusion: It can be thought that AAT can play a role during the course of acute leukemia management. [GRAPHICS]en_US
dc.identifier.doi10.2217/bmm-2023-0415
dc.identifier.issn1752-0363
dc.identifier.issn1752-0371
dc.identifier.pmid38197403en_US
dc.identifier.scopus2-s2.0-85182273362en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org10.2217/bmm-2023-0415
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4593
dc.identifier.wosWOS:001139609700001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherFuture Medicine Ltden_US
dc.relation.ispartofBiomarkers In Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectAaten_US
dc.subjectAcute Lymphoblastic Leukemiaen_US
dc.subjectAcute Myeloid Leukemiaen_US
dc.subjectInfectionen_US
dc.subjectResponseen_US
dc.titleAAT: does it have a place in acute leukemia?en_US
dc.typeArticleen_US

Dosyalar